Benzphetamine |
Didrex |
Article: Benzphetamine
![]() | |
| Benzphetamine | |
| Systematic (IUPAC) name | |
| N-benzyl-N-methyl-1-phenyl-propan-2-amine | |
| Identifiers | |
| CAS number | 156-08-1 |
| ATC code | ? |
| PubChem | 2341 |
| DrugBank | APRD00759 |
| Chemical data | |
| Formula | C17H21N |
| Mol. weight | 239.355 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 75-99% |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | |
| Routes | ? |
Benzphetamine (brand name: Didrex) is an anti-obesity drug marketed under this brand in the USA by Pharmacia. Benzphetamine is used as a short term adjunct in management of exogenous obesity. It is closely related to amphetamine.
Categories: Hallucinogen stubs | Amphetamines | Anorectics | Obesity
Resources
- Benzphetamine (Drug Digest)
- Didrex (Drug Digest)

Not Signed In - 

